Citation: Rm. Stone, A 67-YEAR-OLD RENAL-TRANSPLANT RECIPIENT WITH ANEMIA, LEUKOPENIA, ANDPULMONARY-LESIONS - POSTTRANSPLANTATION LYMPHOPROLIFERATIVE-DISORDER,MONOMORPHIC B-CELL TYPE - BRONCHIOLITIS-OBLITERANS (VOL 337, PG 1065,1997), The New England journal of medicine, 338(2), 1998, pp. 139-139
Authors:
LARSON RA
DODGE RK
LINKER CA
STONE RM
POWELL BL
LEE EJ
SCHULMAN P
DAVEY FR
FRANKEL SR
BLOOMFIELD CD
GEORGE SL
SCHIFFER CA
Citation: Ra. Larson et al., A RANDOMIZED CONTROLLED TRIAL OF FILGRASTIM DURING REMISSION INDUCTION AND CONSOLIDATION CHEMOTHERAPY FOR ADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CALGB STUDY-9111, Blood, 92(5), 1998, pp. 1556-1564
Authors:
MACHPASCUAL S
LEGARE RD
LU D
KROON M
NEUBERG D
TANTRAVAHI R
STONE RM
FREEDMAN AS
NADLER LM
GRIBBEN JG
GILLILAND DG
Citation: S. Machpascual et al., PREDICTIVE VALUE OF CLONALITY ASSAYS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANT - A SINGLE INSTITUTION STUDY, Blood, 91(12), 1998, pp. 4496-4503
Authors:
STONE RM
MARK EJ
FERRY JA
TRUONG MT
ZACHARY KC
Citation: Rm. Stone et al., A 67-YEAR-OLD RENAL-TRANSPLANT RECIPIENT WITH ANEMIA, LEUKOPENIA, ANDPULMONARY-LESIONS - POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER,MONOMORPHIC B-CELL TYPE - BRONCHIOLITIS OBLITERANS, The New England journal of medicine, 337(15), 1997, pp. 1065-1074
Authors:
STILL IH
CHERNOVA O
HURD D
STONE RM
COWELL JK
Citation: Ih. Still et al., MOLECULAR CHARACTERIZATION OF THE T(8-13)(P11-Q12) TRANSLOCATION ASSOCIATED WITH AN ATYPICAL MYELOPROLIFERATIVE DISORDER - EVIDENCE FOR 3 DISCRETE LOCI INVOLVED IN MYELOID LEUKEMIAS ON 8P11, Blood, 90(8), 1997, pp. 3136-3141
Authors:
LIOU JR
LIU TC
KANEKI M
ZALESKAS JM
STONE RM
Citation: Jr. Liou et al., CYTOSOLIC DOWN-REGULATION OF MITOGEN-ACTIVATED PROTEIN-KINASES DURINGBRYOSTATIN 1-INDUCED MONOCYTIC DIFFERENTIATION IN HUMAN MYELOID-LEUKEMIA HL-60 CELLS PRETREATED WITH ALL-TRANS-RETINOIC ACID, Blood, 90(10), 1997, pp. 3450-3450
Authors:
KANEKI M
PANDEY P
LIOU JR
STONE RM
KHARBANDA S
KUFE DW
Citation: M. Kaneki et al., ROLE FOR PROTEIN-KINASE C-BETA-II (PKC-BETA-II) AS AN UPSTREAM REGULATOR OF JNK IN PHORBOL ESTER-INDUCED DIFFERENTIATION OF HUMAN MYELOID-LEUKEMIA CELLS, Blood, 90(10), 1997, pp. 737-737
Authors:
STONE RM
BERG DT
GEORGE SL
DODGE RK
PACIUCCI PA
SCHULMAN P
LEE EJ
MOORE JO
POWELL BL
SCHIFFER CA
Citation: Rm. Stone et al., POST REMISSION THERAPY IN OLDER PATIENTS WITH DE-NOVO ACUTE MYELOID-LEUKEMIA (AML) - A RANDOMIZED TRIAL OF MITOXANTRONE INTERMEDIATE DOSE CYTARABINE-V STANDARD-DOSE CYTARABINE (CALBG-8923)/, Blood, 90(10), 1997, pp. 2255-2255
Authors:
MACHPASCUAL S
LEGARE RD
LU D
KROON M
NEUBERG D
STONE RM
FREEDMAN AS
NADLER LM
GRIBBEN JG
GILLILAND DG
Citation: S. Machpascual et al., PREDICTIVE VALUE OF CLONALITY ANALYSIS IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANT (ABMT) - ASINGLE INSTITUTION STUDY, Blood, 90(10), 1997, pp. 2626-2626
Authors:
BERNSTEIN SH
BRUNETTE VL
DAVEY FR
WURSTERHILL D
MAYER RJ
STONE RM
SCHIFFER CA
BLOOMFIELD CD
Citation: Sh. Bernstein et al., ACUTE MYELOID LEUKEMIA-TYPE CHEMOTHERAPY FOR NEWLY-DIAGNOSED PATIENTSWITHOUT ANTECEDENT CYTOPENIAS HAVING MYELODYSPLASTIC SYNDROME AS DEFINED BY FRENCH-AMERICAN-BRITISH CRITERIA - A CANCER AND LEUKEMIA GROUP-B STUDY, Journal of clinical oncology, 14(9), 1996, pp. 2486-2494
Authors:
STONE RM
BERG DT
GEORGE SL
DODGE RK
PACIUCCI PA
SCHULMAN P
LEE EJ
MOORE JO
POWELL BL
SCHIFFER CA
Citation: Rm. Stone et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AFTER INITIAL CHEMOTHERAPY FOR ELDERLY PATIENTS WITH PRIMARY ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(25), 1995, pp. 1671-1677
Authors:
LARSON RA
DODGE RK
BURNS CP
LEE EJ
STONE RM
SCHULMAN P
DUGGAN D
DAVEY FR
SOBOL RE
FRANKEL SR
HOOBERMAN AL
WESTBROOK CA
ARTHUR DC
GEORGE SL
BLOOMFIELD CD
SCHIFFER CA
Citation: Ra. Larson et al., A 5-DRUG REMISSION INDUCTION REGIMEN WITH INTENSIVE CONSOLIDATION FORADULTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA - CANCER AND LEUKEMIA GROUP-B STUDY-8811, Blood, 85(8), 1995, pp. 2025-2037
Authors:
INHORN RC
ASTER JC
ROACH SA
SLAPAK CA
SOIFFER R
TANTRAVAHI R
STONE RM
Citation: Rc. Inhorn et al., A SYNDROME OF LYMPHOBLASTIC LYMPHOMA, EOSINOPHILIA, AND MYELOID HYPERPLASIA MALIGNANCY ASSOCIATED WITH T(8-13) (P11-Q11) - DESCRIPTION OF ADISTINCTIVE CLINICOPATHOLOGICAL ENTITY, Blood, 85(7), 1995, pp. 1881-1887
Authors:
MCKEOWNEYSSEN GE
BRIGHTSEE E
BRUCE WR
JAZMAJI V
COLE LJ
FEINMAN SV
MYERS ED
NEWMAN A
STERN HS
HAMILTON JD
RUDD WWH
RUDERMAN RL
MOORE TL
OTTAWAY CA
PROKIPUCHUK EJ
COHEN Z
GREENBERG GR
JEEJEBHOY KN
MCLEOD RS
TAYLOR BR
WOLMAN SL
BAKER JP
HIMAL HS
MATHEWS RE
MCHUGH SM
STONE RM
WEIZEL HAE
WRIGHT JR
HABER GB
JAMIESON CR
KORTAN P
MACKENZIE RL
MARCON NE
MURTHI MST
RICHARDSON BJ
ROSS TM
STAFFORD SE
PTAK TW
Citation: Ge. Mckeowneyssen et al., A RANDOMIZED TRIAL OF A LOW-FAT HIGH-FIBER DIET IN THE RECURRENCE OF COLORECTAL POLYPS, Journal of clinical epidemiology, 47(5), 1994, pp. 525-536
Authors:
STONE RM
NEUBERG D
SOIFFER R
TAKVORIAN T
WHELAN M
RABINOWE SN
ASTER JC
LEAVITT P
MAUCH P
FREEDMAN AS
NADLER LM
Citation: Rm. Stone et al., MYELODYSPLASTIC SYNDROME AS A LATE COMPLICATION FOLLOWING AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(12), 1994, pp. 2535-2542
Authors:
STONE RM
BERNSTEIN SH
DEMETRI G
FACKLAM DP
ARTHUR K
ANDERSEN J
ASTER JC
KUFE D
Citation: Rm. Stone et al., THERAPY WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia research, 18(10), 1994, pp. 769-776
Authors:
YANG KD
MIZOBUCHI T
KHARBANDA SM
DATTA R
HUBERMAN E
KUFE DW
STONE RM
Citation: Kd. Yang et al., ALL-TRANS-RETINOIC ACID REVERSES PHORBOL ESTER RESISTANCE IN A HUMAN MYELOID-LEUKEMIA CELL-LINE, Blood, 83(2), 1994, pp. 490-496
Citation: Rm. Stone, MYELODYSPLASTIC SYNDROME AFTER AUTOLOGOUS TRANSPLANTATION FOR LYMPHOMA - THE PRICE OF PROGRESS, Blood, 83(12), 1994, pp. 3437-3440
Authors:
STONE RM
TORIGOE PS
BERG DT
MIZOBUCHI T
MAYER RJ
CANNISTRA SA
Citation: Rm. Stone et al., INTERLEUKIN-3 (IL-3) BEFORE AND DURING INTERMITTENT CONTINUOUS-INFUSION HIGH-DOSE ARA-C (ICHDAC) THERAPY FOR REFRACTORY OR SECONDARY ACUTE MYELOID-LEUKEMIA (AML), Blood, 82(10), 1993, pp. 10000130-10000130